Efficacy and safety of statins for nonalcoholic/metabolic dysfunction-associated fatty liver diseases: a systematic review and meta-analysis
Statins could improve liver function and lipid profiles in NAFLD/MAFLD. No myalgia was reported as AEs in the studies we included and the overall safety was favorable.<b>Protocol registration:</b> www.crd.york.ac.uk/prospero identifier is CRD42025630809.
Authors
- Xingshun Qi (ORCID: https://orcid.org/0000-0002-9448-6739)
- Qihong Wu (ORCID: https://orcid.org/0000-0002-8625-0777)
- Lu Chai
- Nahúm Méndez-Sánchez (ORCID: https://orcid.org/0000-0001-5257-8048)
- Zhenhua Tong (ORCID: https://orcid.org/0000-0002-2178-2457)
- Xiaohui Fang (ORCID: https://orcid.org/0000-0003-4349-0743)
- Yuhang Yin (ORCID: https://orcid.org/0000-0002-3812-0134)
- Yifan Guo (ORCID: https://orcid.org/0009-0008-9281-6440)
Institutions
- Shenyang Pharmaceutical University (CN)
- Northern Hospital (AU)
- Hospital Médica Sur (MX)
- General Hospital of Shenyang Military Region (CN)
- Command Hospital (IN)
- Universidad Nacional Autónoma de México (MX)
- China Medical University (CN)
Publication Details
- Journal
- Expert Review of Clinical Pharmacology
- Published
- 2025-12-02
- DOI
- https://doi.org/10.1080/17512433.2025.2600410
- Citations
- 1
- Primary Topic
- Liver Disease Diagnosis and Treatment
- Type
- article
- Field-Weighted Citation Impact
- 1.35